CenterPoint Energy (CNP)
NYSEUtilitiesUtilities - Regulated ElectricSnapshot 2026-07-07
$44.49+1.11%
Close 2026-07-07 · 1-day change
Reading CNP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CNP free→NYSEUtilitiesUtilities - Regulated ElectricSnapshot 2026-07-07
Reading CNP? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track CNP free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Multi-Utilities is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
CenterPoint Energy's growth depends on strong earnings and performance in the utilities sector. Recent financial results show a beat with earnings per share of 0.56. It trades at 2.5 times book value, which is above the peer median of 2.3 times. Expectations seem modest compared to the growth we forecast. If the company cuts guidance, it could negatively impact the stock. Peer multiples imply a price about 18% below where it trades; this read is provisional.
Trailing returns as of 2026-07-07. CNP is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 18 analysts currently covering CNP (as of Jul 2026).
Based on 5 Wall Street analysts offering 12-month price targets for CNP in the last 4 months.
A consensus fair price across 11 valuation methods, at three horizons. Current price $44.49. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Multi-Utilities — fair value, gap to price, and forward P/E.
Earnings beat supports EPS growth guidance.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-07. EPS is implied from price ÷ P/E. Not investment advice.
Current $44.49
The last 12 months of price, then the range of analyst 12-month targets from today’s $44.49.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Revenue decline raises concerns about future growth.
Earnings beat supports EPS growth expectations.
Exit from midstream aligns with capital allocation strategy.
Acquisition aligns with growth strategy.